IMPAIRMENT CHARGES (Details) (USD $)	3 Months Ended				3 Months Ended
	Mar. 31, 2011	Jun. 30, 2011		Dec. 31, 2010	Jun. 30, 2011 Intangible asset AMRIX	Jun. 30, 2011 Intangible asset TRISENOX	Jun. 30, 2011 Equipment AMRIX	Jun. 30, 2011 Mepha GmbH IPR&D	Jun. 30, 2011 AMRIX	May 31, 2011 AMRIX
Impairment charges
Number of US Patents at Issue Found Invalid by Court in AMRIX Patent Litigation										2
Impairment charges	$ 6,100,000				$ 41,900,000		$ 1,400,000	$ 5,200,000
Credit to cost of goods sold to reverse a previously accrued liability for sales-based milestones									27,800,000
Intangible assets		1,724,246,000	[1]	1,212,387,000		15,700,000			27,600,000
Reduction in the carrying value of the intangible assets						$ 44,300,000

[1] Amounts include assets and liabilities of our variable interest entities (VIEs). Our interests and obligations with respect to VIEs' assets and liabilities are limited to those accorded to us in our agreements with our VIEs. See Note 2 to these consolidated financial statements for amounts.